Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat
Pulmonary hypertension (PH) is a severe and often rapidly progressive disease with fatal outcome. Endothelial dysfunction in PH is associated with decreased nitric oxide production. After reviewing the mechanisms of action and the evidence base for specific therapy with phosphodiesterase 5 inhibitor...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | RU |
| Publicado: |
"Consilium Medicum" Publishing house
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/79df2c4b933a4945b3d6168494d66700 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|